Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 11, 2012, Pages 1165-1170

  Kang, Jun Hyuk ^a   Lee, Dae In ^a   Kim, Sua ^a   Kim, Mi Na ^a   Park, Yae Min ^a   Ban, Ji Eun ^a   Choi, Jong Il ^a   Lim, Hong Euy ^a   Park, Sang Weon ^a   Kim, Young Hoon ^a  

^a College of Medicine   (South Korea)

Author keywords

atrial fibrillation; cardioversion; catheter ablation; left atrium; pulmonary vein isolation

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVERSION; CATHETER ABLATION; DIABETES MELLITUS; DIRECT CURRENT CARDIOVERSION; DISEASE DURATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSISTENT HEART ATRIUM FIBRILLATION; PRIORITY JOURNAL; PROGNOSIS; SINUS RHYTHM; TREATMENT OUTCOME;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BODY MASS INDEX; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DIABETES MELLITUS; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84869096279     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02339.x     Document Type: Article

References (24)

1. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA,; CHARM Investigators: Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failureâ Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006; 47: 1997-2004.
2. Wolf P, Abbott R, Kannel W,: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
3. Benjamin E, Wolf P, D'Agostino R, Silbershatz H, Kannel W, Levy D,: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952.
4. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ,: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925.
5. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B,: The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36: 1303-1309.
6. Cox J, Schuessler R, Boineau J,: The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000; 12: 2-14.
7. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr., Bates ER, Lehmann MH, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V, Morady F,: Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006; 354: 934-941.
8. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H,: High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006; 108: 346-353.
9. Lellouche N, Berthier R, Mekontso-Dessap A, Braconnier F, Monin JL, Duval AM, Dubois-Randé JL, Guéret P, Garot J,: Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. Am J Cardiol 2005; 95: 1380-1382.
10. Okcun B, Yi it Z, Arat A, Baran T, Kucuko lu M,: Stunning of the left atrium after conversion of atrial fibrillation: Predictor for maintenance of sinus rhythm? Echocardiography 2005; 22: 402-427.
11. Dethy M, Chassat C, Roy D, Mercier L,: Doppler echocardiographic predictors of recurrence of atrial fibrillation after cardioversion. Am J Cardiol 1988; 62: 723-726.
12. Calkins H, Brugada J, Packer DL, Cappato R, Chan SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ,: Heart Rhythm Society; European Heart Rhythm Association; European Cardiac Arrhythmia Society; American College of Cardiology; American Heart Association; Society of Thoracic Surgeons: HRS/EHRA/ECAS expert consensus statement on catheter ablation and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. Europace. 2007; 9: 335-379.
13. Kim S, Knight B,: Electrical and pharmacologic cardioversion for atrial fibrillation. Cardiol Clin 2009; 27: 95-107.
14. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,: American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace 2006; 8: 651-745.
15. Stiles MK, Brooks AG, John B, Wilson L, Kuklik P, Dimitri H, Lau DH, Roberts-Thomson RL, Mackenzie L, Willoughby S, Young GD, Sanders P,: The effect of electrogram duration on quantification of complex fractionated atrial electrograms and dominant frequency. J Cardiovasc Electrophysiol 2008; 19: 252-258.
16. Park JH, Pak HN, Kim SK, Jang JK, Choi JI, Lim HE, Hwang C, Kim YH,: Electrophysiologic characteristics of complex fractionated atrial electrograms in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009; 20: 266-272.
17. Yasuda T, Kumagai K, Ogawa F, Noguchi H, Hideaki T, Matsumoto N,: Predictors of successful catheter ablation for atrial fibrillation using the pulmonary vein isolation. J Cardiol 2004; 44: 53-58.
18. Verma A, Marrouche NF, Yamada H, Grimm RA, Cummings J, Burkhardt JD, Kilicaslan F, Bhargava M, Karim AA, Thomas JD, Natale A,: Usefulness of intracardiac Doppler assessment of left atrial function immediately post-pulmonary vein antrum isolation to predict short-term recurrence of atrial fibrillation. Am J Cardiol 2004; 94: 951-954.
19. Vasamreddy CR, Lickfett L, Jayam VK, Nasir K, Bradley DJ, Eldadah Z, Dickfeld T, Berger R, Calkins H,: Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated tip ablation catheter. J Cardiovasc Electrophysiol 2004; 15: 692-697.
20. Themistoclakis S, Schweikert RA, Saliba WI, Bonso A, Rossillo A, Bader G, Wazni O, Burkhardt DJ, Raviele A, Natale A,: Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm 2008; 5: 679-685.
21. Cha YM, Friedman PA, Asirvatham SJ, Shen WK, Munger TM, Rea RF, Brady PA, Jahangir A, Monahan KH, Hodge DO, Meverden RA, Gersh BJ, Hammill SC, Packer DL,: Catheter ablation for atrial fibrillation in patients with obesity. Circulation 2008; 117: 2583-2590.
22. Oral H, Chugh A, Scharf C, Hall B, Cheung P, Veerareddy S, Daneshvar GF, Pelosi F Jr, Morady F,: Pulmonary vein isolation for vagotonic, adrenergic, and random episodes of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15: 402-406.
23. Richter B, Gwechenberger M, Filzmoser P, Marx M, Lercher P, Gossinger H,: Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor? Eur Heart J 2006; 27: 2553-2559.
24. Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clémenty J, Haïssaguerre M,: Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498-2505.